Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In ChinaThis study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.
In United Kingdom
This study is recruiting in the United States. It is testing adverse Events and Change for Bipolarity.
Multiple locations, including HuntsvilleThis study is recruiting in the United States. It is testing adverse Events, Change for schizophrenia.
Multiple locations, including Little RockThis study is recruiting in the United States and in Russian Federation. It is testing change for depression.
Multiple locations, including BentonvilleThis study is recruiting in the United States. It is testing change for depression.
Multiple locations, including DothanThis study is recruiting in the United Kingdom, in Belgium, in Austria, .... It is testing Effectiveness and Efficiency of VNS Therapy for depression.
Multiple locations, including ViennaThis study is recruiting in the United States, in France, in the United Kingdom, .... It is testing KarXT for Schizophrenia.
Multiple locations, including HomewoodThis study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing KarXT for Schizophrenia.
Multiple locations, including ChandlerThis study is recruiting in the United States, in Bulgaria, in Croatia, .... It is testing ITI-1284 for Schizophrenia.
Multiple locations, including AnaheimThis study is recruiting in the United States, in France, in Canada, .... It is testing ML-007C-MA for Schizophrenia.
Multiple locations, including PhoenixThis study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for depression.
Multiple locations, including Tucson